In the BioHarmony Drug Report Database
Campral (acamprosate) is a small molecule pharmaceutical. Acamprosate was first approved as Campral on 2004-07-29. It is used to treat alcoholism in the USA. It is known to target glutamate receptor ionotropic, NMDA 1 and gamma-aminobutyric acid receptor subunit alpha-1.
Image (chem structure or protein)